Diakonos Oncology Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer
Position
Chief Financial Officer
Company
Diakonos Oncology
Description
Diakonos Oncology Corp. appoints Anthony Baldor as Chief Financial Officer.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer (February 22, 2024)
- OncoNano Medicine Appoints Dr. Kartik Krishnan as Chief Executive Officer and Dr. Melissa Paoloni as Executive Vice President and Chief Operating Officer (March 1, 2024)
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer (February 21, 2024)
- Elevation Oncology Appoints Julie Cherrington as Chief Executive Officer and Alan Sandler as Chief Medical Officer (March 4, 2024)
- MBrace Appoints Steve Alley as Chief Scientific Officer (March 5, 2024)
- BioMarin Names Cristin Hubbard as Executive Vice President and Chief Commercial Officer (March 7, 2024)
Who to call at Diakonos Oncology, and when
A new leader at Diakonos Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Diakonos Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Diakonos Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Diakonos Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Diakonos Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Diakonos Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.